THE PATIENT’S AGE, GENDER, HEIGHT, AND WEIGHT AT THE TIME OF COLLECTION MUST BE SUBMITTED FOR NASH FIBROSURE(R) TESTING.
Gel-barrier tube is preferred. Red top tube is acceptable.
Separate serum from cells within two hours of collection.
Patient should be FASTING for at least eight hours.
Refrigerated 72 hours: Frozen 7 days
NASH FibroSure(R) is recommended for patients with suspectednonalcoholic fatty liver disease. It is not recommended for patient with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver,autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis. This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.